CONTACT
ABOUT ABBOTT
cardiovascular
MY ACCOUNT

 

 

XIENCE SKYPOINT™ STENT 4.5 mm & 5.0 mm 

APPROVED WITH LEFT MAIN INDICATION¹

 

 

 

 

            XIENCE™ SIERRA

4.5 and 5.0 mm Sizes

Introducing XIENCE Skypoint™ Stent 4.5 mm and

5.0 mm Sizes, To Treat Large Vessels

XIENCE Skypoint™ Stent delivers the broadest expansion range in the latest generation XIENCE™ Stent, the DES that consistently delivers successful outcomes, not only in the cath-lab but far beyond. Now available in 4.5 mm and 5.0 mm sizes.2

 

 

 

 

 

 

 

Treat a Wide Range of Large Vessel Lesions With XIENCE Skypoint™ Stents4

XIENCE Skypoint™ Stent offers a range of stent lengths from 12 mm to 33 mm to help treat a wide range of patients.4

12 mm
to
33 mm

Stent DiameterStent Length  
       12 mm            15 mm           18 mm             23 mm           28 mm            33 mm          Maximum Expansion  
4.5 mm  ✓✓✓✓✓✓5.75 mm
5.0 mm  ✓✓✓✓✓✓5.75 mm

 

 

 

 

 

 

XIENCE Skypoint™ Stent Shows Accurate Stent Placement with Precise Stent and Marker Placement 5

Accurate mid-marker placement enables precise scaffolding and reduces the likelihood of geographic miss to support optimal patient outcomes.5,6

 

 

 

XIENCE Skypoint™ Stent has Significantly Better Longitudinal Strength Than Other DES in Large Vessels 7

Longitudinal strength supports better scaffolding in large coronary vessels. Less stent deformation delivers better patient outcomes.8

XIENCE Skypoint™ Stent Shows Significantly Less Stent Deformation Than
Synergy‡ and Resolute Onyx‡ - 5.0 mm Stents

*Denotes significantly different when compared with XIENCE Skypoint™ Stent.

 

 

 

 

XIENCE™ Stent Shows Improvements in Measures of Quality of Life (QoL) in Patients With Left Main Lesions at 3 Years 9

 

 

PCI With XIENCE™ Stent in patients with left main lesions showed sustained improvements in QoL out to 3 years9

pci-xience-skypoint-45-50-81-percent-no-angina
pci-xience-skypoint-45-50-81-percent-no-angina

Quality of life is a subscale of the Seattle Angina Questionnaire (SAQ). Scores for each subscale range from 0 to 100 with higher scores representing better health status. Comparison is made Vs baseline.
** Denotes statistically significant difference from baseline.

 

 

 

 

 

 

* Frequency of angina is a subscale of the Seattle Angina Questionnaire (SAQ). Comparison is made vs baseline.
** Denotes statistically significant difference from baseline.

 

 

 

 

 

 

XIENCE™ Stent shows significantly lower definite stent thrombosis rates than Synergy‡ in patients with left main lesions at 2 years 10

 

 

 


References

  1. XIENCE Skypoint™ Stent Instructions For Use (IFU). Refer to IFU for additional information.
  2. XIENCE Skypoint™ Stent – Instructions for Use (IFU). Refer to IFU for additional information. Zanchin, C. et al. J Am Coll Cardiol Intv. 2019;12(17):1665-1675. Serruys P, et al. N Engl J Med. 2010;363:136-146. Kufner S, et al. Circulation. 2019:139(3):325-333.
  3. Data on file at Abbott.
  4. XIENCE Skypoint™ Stent – Instructions for Use (IFU). Refer to IFU for additional information.
  5. Data on file at Abbott. XIENCE Skypoint™ Stent vs. Synergy‡ and Resolute Onyx‡ – 5.0 x 18 or 20 mm stents tested.
  6. Costa M, et al. Am J Cardiol. 2008;101:1704-1711; Sudhir, K., et al. ISRN Cardiology. 2013:1-8.
  7. Data on file at Abbott. XIENCE Skypoint™ Stent – 5.0 x 33 mm, n=5. Synergy‡ 5.0 x 32 mm, n=2. Resolute Onyx‡ – 5.0 x 33 mm , n=5. *Denotes significantly different when compared with XIENCE Skypoint™ Stent. Longitudinal stent compression test was done using 50 gf load.
  8. Shand J, et al. Interv Cardiol. 2012;4:325-335.
  9. Baron S, et al. J Am Coll Cardiol. 2017;70:3113-3122.
  10. Van Geuns R, et al. IDEAL-LM. TCT 2019

MAT-2404068 V1.0

 

Abbott Logo

Information contained herein for distribution in Australia and New Zealand only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events. Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2024 Abbott. All Rights Reserved.

Abbott Vascular division of Abbott Medical New Zealand Ltd, Grd Flr, Bldg. D, 4 Pacific Rise My Wellington, Auckland 1060 Tel: 0800 827 285

Abbott Vascular division of Abbott Medical Australia Pty Ltd, 299 Lane Cove Road, Macquarie Park NSW 2113, Tel: 1800 550 9391

MAT-2105201 v6.0

Disclaimer

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

 

Do you wish to continue and enter this website?

MAT-2105201 v1.0